The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial (275778)
ARTG Name
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial
Product name
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
ocrelizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information